NCT06326853View on ClinicalTrials.gov

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2026

Conditions

Endocrine DisordersAdiposityPituitary AdenomaCushing SyndromeAcromegalyHypopituitarism

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER

NCT06326853 - Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models | Biotech Hunter | Biotech Hunter